the cytisinicline, a cytisinicline - based smoking cessation aid, is a promising drug for smoking cessation. the cytisinicline is a well - tolerated and effective drug for smoking cessation. the results of the new country - controlled phase 3 trial are a landmark because this is the first direct head-to-head comparison of cytisinicline efficacy and safety compared to the current market leader with Chantix. furthermore, we continue to make excellent progress preparing for the commencement of the phase 3 molecular dose - dependent phase 3 trial in the fourth quarter.